Old Web
English
Sign In
Acemap
>
Paper
>
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI)
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI)
2018
Susanne Saussele
Johan Richter
Joelle Guilhot
Franz Gruber
Henrik Hjorth-Hansen
Antonio Almeida
Jeroen J.W.M. Janssen
Jiri Mayer
Perttu Koskenvesa
Panayiotis Panayiotidis
Ulla Olsson-Strömberg
Joaquin Martinez-Lopez
Philippe Rousselot
Hanne Vestergaard
Hans Ehrencrona
Veli Kairisto
Katerina Machova Polakova
Martin C. Mueller
Satu Mustjoki
Marc G Berger
Alice Fabarius
Wolf-Karsten Hofmann
Andreas Hochhaus
Markus Pfirrmann
François-Xavier Mahon
Keywords:
Major Molecular Response
Cancer research
Dasatinib
Nilotinib
Myeloid
Tyrosine-kinase inhibitor
Medicine
Discontinuation
Withdrawal syndrome
Disease
chronic myeloid leukaemia
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]